CClinicalTrials.gg
CompletedNCT00661856SoyPTIUpdated Apr 21, 2008

Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices

An interventional study of Soy protein in Osteoporosis, sponsored by Creighton University. Completed at 1 site in United States. Open to female participants aged 55 Years to 72 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2008-04-21.

Sponsored by Creighton University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
203
Allocation
Randomized
Ages
55 Years to 72 Years
Sex
Female
01

Study summary

The aim of the present study was to investigate the effects of soy and soy plus isoflavones on bone mineral Density and physical performance in post menopausal women.

Read the detailed description

Post menopausal estrogen deficiency causes physiologic changes in body composition including decreased lean body weight and bone mass. A decrease in muscle strength along with osteoporosis puts post menopausal women at a high risk of hip fractures causing considerable mortality and morbidity. Estrogen use has been shown to reduce bone density loss and increase muscle strength but given the concerns regarding its use, patients are looking for alternatives such as Soy isoflavones. Most human studies on the effect of Soy on bone mineral density (BMD) in post menopausal women have been short term i.e. 3-6 months and failed to provide conclusive evidence. There is no evidence of its effects on physical performance.

The aim of the present study is to investigate the effects of 25g of soy protein alone or with 90mg of isoflavones on bone mineral Density and physical performance indices in post menopausal women over a duration of 2 years.

02

Conditions studied

  • Osteoporosis

Browse trials for

Keywords

  • Soy Isoflavones, Bone Mineral Density, Post menopausal women
03

In context

Osteoporosis

1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.

This study's enrollment of 203 is above the median of 95 across 1,133 interventional studies indexed under Osteoporosis.

Browse Osteoporosis studies →

Lead sponsor

Creighton University is the lead sponsor of 126 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 72 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • at least 55-75 years of age
  • at least 7 years post menopausal either spontaneous or surgical

Exclusion criteria

Exclusion Criteria:

  • must not have used estrogen for atleast 2 months prior to entering study
  • must be on no bone active drugs such as bisphosphonates, anti convulsants, calcitonin and long term steroids
  • osteoporosis (T-score\<-2.5)
  • BMI \<18 or >34
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
203 participants (actual)

Study arms

  • Active comparator
    1

    Soy Protein group 25g of Soy protein with no Isoflavones

    Dietary Supplement: Soy protein

  • Experimental
    2

    Soy Isoflavone group 25g of Soy Protein with 90mg of Isoflavones

    Dietary Supplement: Soy protein

  • Placebo comparator
    3

    25g of Milk protein

    Dietary Supplement: Soy protein

Interventions

  • Dietary supplementSoy protein

    25g of Soy protein with or with out 90mg of isoflavones ones a day given for a period of 24 months

    Also known as: genistein, daidzein, glycetein

06

What researchers measure

Primary outcomes

  1. Bone Mineral Density

    Time frame: 24 months

Secondary outcomes

  1. Physical Performance Indices

    Time frame: 24 months

07

Study locations

1 site
  • Creighton University Medical Center
    Omaha, Nebraska 68131, United States
08

References and documents

Publications

  • Gallagher JC, Satpathy R, Rafferty K, Haynatzka V. The effect of soy protein isolate on bone metabolism. Menopause. 2004 May-Jun;11(3):290-8. doi: 10.1097/01.gme.0000097845.95550.71. PubMed 15167308 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 21, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00661856
Lead sponsor
Creighton University
Collaborators
Solae, LLC
First posted
Apr 21, 2008
Start date
Jan 2001
Primary completion
Jan 2004
Completion
Jan 2004
Last update
Apr 21, 2008

Study contacts

J C Gallagher
principal investigator · Creighton University Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion